TickerFacts.

Orchestra BioMed Holdings, Inc. (OBIO): Revenue

Annual figures by period end, from SEC filings.

$33.48M
Year ended 2025-12-31
$31.98M
Trailing 12 months to 2026-06-30
+111.6%
3-year compound annual growth
2022-12-31: $3.53M2023-12-31: $2.76M2024-12-31: $2.64M2025-12-31: $33.48M$33.48M
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$33.48Mn/m2026-03-12, From 2025-01-01
2024-12-31$2.64M-4.4%2026-03-12, From 2024-01-01
2023-12-31$2.76M-21.9%2025-03-31, From 2023-01-01
2022-12-31$3.53Mn/a2024-03-27, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$33.48Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31$31.88M+53.6%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$36.97M+17.8%
Cytosorbents Corp (CTSO)2025-12-31$37.06M+4.1%
Retractable Technologies Inc (RVP)2025-12-31$38.27M+15.8%
Utah Medical Products Inc (UTMD)2025-12-31$38.52M-5.8%
Interpace Biosciences, Inc. (IDXG)2025-12-31$38.73M-17.5%
Sensus Healthcare, Inc. (SRTS)2025-12-31$27.48M-34.3%
KORU Medical Systems, Inc. (KRMD)2025-12-31$41.13M+22.2%

Compare OBIO, PREM, CLPT, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗